Industry news that matters to you.  Learn more

Quintiles, London Genetics Ally To Enhance Drug Discovery And Development Through Pharmacogenetics

Quintiles, the world’s leading bio pharmaceutical services company, and London Genetics, an expert in the use of pharmacogenetics in drug discovery and development, today announced a strategic alliance to offer the bio pharmaceutical industry innovative pharmacogenetics solutions to advance personalized medicine. Financial terms were not disclosed.

Astrimmune Hooks Up With London Genetics for Biomarkers

UK groups London Genetics and Astrimmune are joining forces under a new collaboration to plan a biomarker identification programme for an experimental vaccine for pancreatic cancer.

Diaceutics and London Genetics Partner to Accelerate Biomarker Development in the Global Biopharmaceutical Industry

Diaceutics Limited (http://www.diaceutics.com) and London Genetics Limited, an expert in the use of pharmacogenetics in clinical drug discovery and development, today announce a strategic partnership to develop software decision tools that will provide biopharmaceutical companies with rapid and extensive access to the world’s leading academic biomarker research groups. The new tools will enable commercial biomarker research teams to comprehensively explore global biomarker resources to identify genes and gene sequences, as well as the researchers and clinicians relevant to their targeted therapy research.